3Dバイオプリンティング人体組織市場レポート：2030年までの動向、予測、競合分析

3Dバイオプリンティング人体組織の動向と予測

世界の3Dバイオプリンティング人体組織市場は、2024年から2030年までのCAGRが7.8%で、2030年までに推定34億米ドルに達すると予測されています。この市場の主な促進要因は、免疫細胞療法への傾斜の高まり、技術の進歩、カスタマイズされた3Dプリンティング、組織工学、臓器置換に対する需要の高まりです。世界の3Dバイオプリンティング人体組織市場の将来は、組織工学、美容整形、薬物試験・開発、食品試験市場に機会があり、有望です。

3Dバイオプリンティング人体組織市場の洞察

Lucintelの予測では、臨床試験アプリケーションでの採用が増加しているため、薬剤試験と開発が予測期間中に最も高い成長を示す見込みです。

北米は、政府の研究開発費の増加により、予測期間中最大の地域となる見込みです。

よくある質問

Q1.市場規模は？

A1.世界の3Dバイオプリンティング人体組織市場は、2030年までに推定34億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の3Dバイオプリンティング人体組織市場は、2024年から2030年にかけてCAGR 7.8%で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、免疫細胞療法への傾斜の高まり、技術の進歩、カスタマイズされた3Dプリンティング、組織工学、臓器置換に対する需要の高まりです。

Q4.市場の主要セグメントは？

A4.3Dバイオプリンティング人体組織市場の将来は、組織工学、美容整形、薬物試験・開発、食品検査市場に機会があり、有望です。

Q5.市場の主要企業は？

A5.3Dバイオプリンティング人体組織の主要企業は以下の通り。

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、臨床試験アプリケーションでの採用が増加しているため、薬剤試験と開発が予測期間中に最も高い成長を示すと予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、政府の研究開発費の増加により、予測期間中最大の地域です。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の3Dバイオプリンティング人体組織市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の3Dバイオプリンティング人体組織市場動向（2018～2023年）と予測（2024～2030年）
• アプリケーション別の世界の3Dバイオプリンティング人体組織市場
  • 人体組織工学
  • 美容整形
  • 薬物の試験と開発
  • 食品検査
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の3Dバイオプリンティング人体組織市場
• 北米の3Dバイオプリンティング人体組織市場
• 欧州の3Dバイオプリンティング人体組織市場
• アジア太平洋の3Dバイオプリンティング人体組織市場
• その他地域の3Dバイオプリンティング人体組織市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • アプリケーション別の世界の3Dバイオプリンティング人体組織市場の成長機会
  • 地域別の世界の3Dバイオプリンティング人体組織市場の成長機会
• 世界の3Dバイオプリンティング人体組織市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の3Dバイオプリンティング人体組織市場の能力拡大
  • 世界の3Dバイオプリンティング人体組織市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

3D Bioprinted Human Tissue Trends and Forecast

The future of the global 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets. The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

A more than 150-page report is developed to help in your business decisions.

3D Bioprinted Human Tissue by Segment

The study includes a forecast for the global 3D bioprinted human tissue by application and region.

3D Bioprinted Human Tissue Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Tissue Engineering
• Cosmetic Surgery
• Drug Testing and Development
• Food Testing
• Others

3D Bioprinted Human Tissue Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of 3D Bioprinted Human Tissue Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies 3D bioprinted human tissue companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D bioprinted human tissue companies profiled in this report include-

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

3D Bioprinted Human Tissue Market Insights

Lucintel forecasts that drug testing and dvelopment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.

North America will reamin the largest region over the forecast period due to rising government R&D spending.

Features of the Global 3D Bioprinted Human Tissue Market

Market Size Estimates: 3D bioprinted human tissue market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: 3D bioprinted human tissue market size by application and region in terms of value ($B).

Regional Analysis: 3D bioprinted human tissue market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications and regions for the 3D bioprinted human tissue market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 3D bioprinted human tissue market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the 3D bioprinted human tissue market size?

Answer: The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030.

Q2. What is the growth forecast for 3D bioprinted human tissue market?

Answer: The global 3D bioprinted human tissue market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the 3D bioprinted human tissue market?

Answer: The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

Q4. What are the major segments for 3D bioprinted human tissue market?

Answer: The future of the 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets.

Q5. Who are the key 3D bioprinted human tissue market companies?

Answer: Some of the key 3D bioprinted human tissue companies are as follows.

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

Q6. Which 3D bioprinted human tissue market segment will be the largest in future?

Answer: Lucintel forecasts that drug testing and dvelopment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.

Q7. In 3D bioprinted human tissue market, which region is expected to be the largest in next 5 years?

Answer: North America will reamin the largest region over the forecast period due to rising government R&D spending.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the 3D bioprinted human tissue market by application (tissue engineering, cosmetic surgery, drug testing and development, food testing, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global 3D Bioprinted Human Tissue Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global 3D Bioprinted Human Tissue Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global 3D Bioprinted Human Tissue Market by Application
  • 3.3.1: Tissue Engineering
  • 3.3.2: Cosmetic Surgery
  • 3.3.3: Drug Testing and Development
  • 3.3.4: Food Testing
  • 3.3.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global 3D Bioprinted Human Tissue Market by Region
• 4.2: North American 3D Bioprinted Human Tissue Market
• 4.3: European 3D Bioprinted Human Tissue Market
  • 4.3.1: European 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.4: APAC 3D Bioprinted Human Tissue Market
  • 4.4.1: APAC 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.5: ROW 3D Bioprinted Human Tissue Market
  • 4.5.1: ROW 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Application
  • 6.1.2: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Region
• 6.2: Emerging Trends in the Global 3D Bioprinted Human Tissue Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global 3D Bioprinted Human Tissue Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global 3D Bioprinted Human Tissue Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Organovo
• 7.2: Stratasys
• 7.3: 3D Systems
• 7.4: SOLS Systems
• 7.5: Youbionic